Fda Expands Access To Pancreatic Cancer Drug Helping Patients Like Ben Sasse

The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use. The medication, daraxonrasib, is a 300 milligram pill taken once a day. The drug ...Read more